PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PolyPeptide Group AG
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Capital Expenditures
-€56.7m
CAGR 3-Years
-10%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Capital Expenditures
-CHf292.6m
CAGR 3-Years
-47%
CAGR 5-Years
-56%
CAGR 10-Years
-40%
Siegfried Holding AG
SIX:SFZN
Capital Expenditures
-CHf139.1m
CAGR 3-Years
-11%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Capital Expenditures
-CHf1.6B
CAGR 3-Years
-13%
CAGR 5-Years
-19%
CAGR 10-Years
-23%
Tecan Group AG
SIX:TECN
Capital Expenditures
-CHf28.9m
CAGR 3-Years
12%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Capital Expenditures
-CHf35.3m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
921.9m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
24.99 CHF
Overvaluation 11%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Capital Expenditures?
Capital Expenditures
-56.7m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Capital Expenditures amounts to -56.7m EUR.

What is PolyPeptide Group AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-25%

Over the last year, the Capital Expenditures growth was 28%. The average annual Capital Expenditures growth rates for PolyPeptide Group AG have been -10% over the past three years , -25% over the past five years .

Back to Top